Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: A cluster randomized trial in Karachi, Pakistan

Vaccine

Volumn 30, Issue 36, 2012, Pages 5389-5395

  Khan, M Imran ^a   Soofi, Sajid Bashir ^b   Ochiai, R Leon ^a   Habib, Mohammad Atif ^b   Sahito, Shah Muhammad ^b   Nizami, S Qamaruddin ^b   Acosta, Camilo J ^a   Clemens, John D ^a   Bhutta, Zulfiqar A ^b  

^a International Vaccine Institute   (South Korea)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Developing countries; Immunogenicity; Pakistan; Typhoid fever; Typhoid vaccine

Indexed keywords

ANTIBODY; HEPATITIS A VACCINE; TYPHOID VACCINE; UNCLASSIFIED DRUG; VI CAPSULAR POLYSACCHARIDE TYPHOID VACCINE;

ANTIBODY PRODUCTION; ARTICLE; CHINA; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; FOLLOW UP; HEPATITIS A; HUMAN; IMMUNE RESPONSE; IMMUNITY; INDIA; INJECTION SITE PAIN; NEPAL; PAKISTAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS; SOUTH AFRICA; TYPHOID FEVER; URBAN AREA; VACCINATION;

ADOLESCENT; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A VACCINES; HUMANS; INCIDENCE; MALE; PAKISTAN; POLYSACCHARIDES, BACTERIAL; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; VACCINATION;

EID: 84864014095     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.015     Document Type: Article

References (25)

1. World Health Organization Typhoid vaccines: WHO position paper. Weekly Epidemiol Rec 2008, 83(6):49-59.
2. Fraser A., Goldberg E., Acosta C.J., Paul M., Leibovici L. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 2007, (3):CD001261.
3. Levine M.M., Ferreccio C., Cryz S., Ortiz E. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomized controlled field trial. Lancet 1990, 336(8720):891-894.
4. Simanjuntak C.H., Paleologo F.P., Punjabi N.H., Darmowigoto R., Soeprawoto, Totosudirjo H., et al. Oral immunization against typhoid fever in Indonesia with Ty21a vaccine. Lancet 1991, 338(8774):1055-1059.
5. Acharya I.L., Lowe C.U., Thapa R., Gurubacharya V.L., Shrestha M.B., Cadoz M., et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. New Engl J Med 1987, 317(18):1101-1104.
6. Tacket C.O., Ferreccio C., Robbins J.B., Tsai C.M., Schulz D., Cadoz M., et al. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis 1986, 154(2):342-345.
7. Tacket C.O., Levine M.M., Robbins J.B. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever. Vaccine 1988, 6(4):307-308.
8. Klugman K.P., Gilbertson I.T., Koornhof H.J., Robbins J.B., Schneerson R., Schulz D., et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987, 2(8569):1165-1169.
9. Yang H.H., Wu C.G., Xie G.Z., Gu Q.W., Wang B.R., Wang L.Y., et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull World Health Organ 2001, 79(7):625-631.
10. Sur D., Ochiai R.L., Bhattacharya S.K., Ganguly N.K., Ali M., Manna B., et al. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. New Engl J Med 2009, 361(4):335-344.
11. Halloran M.E., Haber M., Longini I.M., Struchiner C.J. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol 1991, 133(4):323-331.
12. Ochiai R.L., Acosta C.J., Danovaro-Holliday M.C., Baiqing D., Bhattacharya S.K., Agtini M.D., et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008, 86(4):260-268.
13. World Health Organization. WHO Draft Guidelines for Adverse Event Reporting and Learning Systems: From Information to Action. WHO/EIP/SPO/QPS/05.3. 2005. http://www.who.int/patientsafety/events/05/Reporting_Guidelines.pdf.
14. International Conference on Harmonisation E9 Expert Working Group. ICH harmonised tripartite guideline: guideline for good clinical practice E6 (R1). 1996. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1_Guideline.pdf.
15. Khan M.I., Sahito S.M., Khan M.J., Wassan S.M., Shaikh A.W., Maheshwari A.K., et al. Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial. Bull World Health Organ 2006, 84(1):72-77.
16. Murray P., Rosenthal K., Kobayashi G., Pfaller M. Medical microbiology 2005, Mosby/Elsvier Science, St. Louis.
17. Lebacq E. Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration. BioDrugs 2001, 15(Suppl. 1):5-12.
18. Hayes R.J., Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 1999, 28(2):319-326.
19. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42(1):121-130.
20. Lin D.Y., Wei L.J. The robust inference for the cox proportional hazards model. J Am Stat Assoc 1989, 84(408):1074-1078.
21. Pelser H.H. Reactogenicity and immunogenicity of a single dose of typhoid Vi polysaccharide vaccine in children aged between 4 and 14 years. BioDrugs 2001, 15(Suppl. 1):13-19.
22. Klugman K.P., Koornhof H.J., Robbins J.B., Le Cam N.N. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996, 14(5):435-438.
23. Agtini M.D., Ochiai R.L., Soeharno R., Lee H.J., Sundoro J., Hadinegoro S.R., et al. Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform. Public Health 2006, 120(11):1081-1087.
24. Thiem V.D., Danovaro-Holliday M.C., Canh do G., Son N.D., Hoa N.T., Thuy D.T., et al. The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy. Southeast Asian J Trop Med Public Health 2006, 37(3):515-522.
25. Bodhidatta L., Taylor D.N., Thisyakorn U., Echeverria P. Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine. Rev Infect Dis 1987, 9(4):841-845.